October 5, 2022
UC San Diego Health is the first hospital system in the region to offer a novel treatment option for patients with prostate cancer that has spread throughout the body and has not responded to other therapeutics.
June 18, 2018
…driving cars and testing nuclear missiles—have impacted the Earth’s atmosphere over time. Cleansing the Earth’s environment is of growing interest in the new era of humanity, unofficially called the Anthropocene epoch. To better understand the impact of the human biogeochemical footprint on Earth, scientists at the University of California San…
September 16, 2012
Chemists at UC San Diego have developed a method that for the first time provides scientists the ability to attach chemical probes onto proteins and subsequently remove them in a repeatable cycle.
July 2, 2014
…San Diego School of Medicine, Oregon Health & Science University (OHSU) and Salk Institute for Biological Studies has shown for the first time that stem cells created using different methods produce differing cells. The findings, published in the July 2, 2014 online issue of Nature, provide new insights into the…
November 10, 2011
…at the University of California, San Diego School of Medicine say this process is even more complex than previously thought, with regulated genes actually relocated to other, more conducive places in the cell nucleus.
February 16, 2012
In a step toward deciphering the “splicing code” of the human genome, researchers at the University of California, San Diego School of Medicine have comprehensively analyzed six of the more highly expressed RNA binding proteins collectively known as heterogeneous nuclear ribonucleoparticle (hnRNP) proteins.
February 17, 2016
John Holdren, President Barack Obama’s senior science and technology advisor, will speak at the University of California, San Diego for the fifth annual Herb York Memorial Lecture on Monday, Feb. 29. A keynote event for the UC Institute on Global Conflict and Cooperation (IGCC), the visit is cosponsored by the…
September 27, 2011
A study by scientists at the University of California, San Diego and UC Irvine has identified an enzyme called a proteasome phosphatase that appears to regulate removal of damaged proteins from a cell. The understanding of how this process works could have important implications for numerous diseases, including cancer and…
February 1, 2017
…San Diego School of Medicine and Moores Cancer Center, in collaboration with colleagues at Rady Children’s Hospital-San Diego, the University of Colorado School of Medicine and SignalRx, a San Diego-based biopharmaceutical company, describe a potential new class of anti-cancer drugs that inhibit two or more molecular targets at once, maximizing…
October 5, 2015
Under its new 4D Nucleome Program, the National Institutes of Health (NIH) Common Fund has awarded three grants totaling more than $30 million over five years to multidisciplinary teams of researchers at University of California, San Diego.
